Cape Verde vs North Korea: Women's share of population ages 15+ living with HIV
Cape Verde
47.5%
in 2024
North Korea
48.1%
in 2024
Cape Verde rank
54th
North Korea rank
53rd
Women's share of population ages 15+ living with HIV over time
- Cape Verde
- North Korea
How they compare
North Korea currently reports 48.1% against 47.5% in Cape Verde, a difference of 0.6%.
Across all 35 years both countries report, North Korea has been ahead every year.
Cape Verde ranks 54th and North Korea ranks 53rd of 172 countries.
North Korea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cape Verde | North Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 47.3% | 48.4% | 1.1% | North Korea |
| 2000s | 46.6% | 48.8% | 2.2% | North Korea |
| 2010s | 45.7% | 48.5% | 2.8% | North Korea |
| 2020s | 47.1% | 48.2% | 1.1% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Cape Verde or North Korea?
- North Korea, at 48.1% against 47.5% in Cape Verde as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Cape Verde and North Korea?
- 0.6%, with North Korea ahead.
- How many years of comparable data are there for Cape Verde and North Korea?
- 35 years are reported by both, from 1990 to 2024.
- How do Cape Verde and North Korea rank globally for women's share of population ages 15+ living with hiv?
- Cape Verde ranks 54th and North Korea ranks 53rd of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.